Neuro-326x280

Butterbur Extract is Found to Reduce Migraine Attacks!

Two New Studies Demonstrate Effectiveness Of Butterbur Extract To Prevent Migraine Headaches in Both Adults and Children
New York – February 23, 2005 – Two new research studies using an over the counter herbal extract from Butterbur, give new hope to the estimated 28 million Americans who regularly suffer from debilitating migraine headaches.

A new study to be published in the March 2005 issue of the journal Headache, finds that 77 percent of children between the ages of 6 and 17, taking a non-prescription extract of petasites hybridus root (manufactured under the brand name Petadolex), had the number of migraine attacks reduced by 50 percent or more.

Butterbur Extract for Adults & Children!

After four months of treatment, the number of overall migraine attacks was cut by 63 percent and when the children did experience a migraine, 66.7 percent of the younger children (ages 6-9) and 61.1 percent of the adolescents (ages 10-17) found the headaches were of shorter duration than without treatment.

A second study recently published in the journal Neurology (Vol, 63, Issue 12) found similar results in adults who were prohylactically treated with Petadolex. The double blind, placebo controlled study, conducted by research at the Albert Einstein College of Medicine in New York, followed 245 adults with a history of migraine. Taking 150mg a day of Petadolex significantly reduced the number of migraine attacks by 48 percent (compared to 26 percent among those taking a placebo). More than two thirds of patients taking Petadolex experienced a 50 percent or greater reduction in the number of migraines they experienced.

Dr Richard Lipton, vice chairman and professor of Neurology at Albert Einstein School of Medicine and senior author of the study, said, “Our study shows that butterbur really does reduce the frequency of migraine attacks, so it’s a welcome addition to the therapeutic arsenal we have to combat migraine.”

A patented unique preparation of the traditional butterbur extract sold under the brand name Petadolex was used in both trials. Standardized to contain a minimum of petasins, the extract is manufactured by Weber and Weber, a phytomedicine company with a worldwide reputation for developing high-quality herbal remedies used to successfully treat a wide variety of ailments for more than 50 years.

Butterbur extract has been used for medicinal purposes since ancient times. Previous research and clinical use of the special butterbur root extract has shown that it has a high safety profile. There were few side effects from butterbur in the new clinical trials; the most commonly observed being mild gastrointestinal symptoms.

According to the National Headache Foundation, upwards of 45 million Americans suffer chronic, recurring headaches, significantly more than the 33 million sufferers of asthma, diabetes and coronary heart disease combined. Of these, 28 million suffer from migraines annually. Moreover, it is estimated that industry loses 50 billion dollars per year due to absenteeism and medical expenses caused by headache. The Foundation estimates that migraine sufferers lose more than 157 million workdays each year.

Consumers looking for more information about Petadolex and butterbur extract, you can go to our Petadolex review page

Tags:
Previous Post
Headache-Happiness-326x280
eBooks

Headache ebook: Headache Happiness

Next Post
Petadolex-75mg-326x280
Articles

Non-Addictive Medication Recognized as Safe for Migrainers

Leave a Reply